-+ 0.00%
-+ 0.00%
-+ 0.00%

Mira Pharmaceuticals startet letzte Phase-1-Kohorte für Ketamir-2 und plant Phase-2a-Studie

Reuters·02/02/2026 21:02:24

Please log in to view news